President Trump is readying plans for industry-specific tariffs to kick in alongside his country-by-country duties in two ...

Duquesne Family Office's billionaire chief dumped his fund's stake in Wall Street's artificial intelligence (AI) darling in ...

We came across a bullish thesis on Verona Pharma plc (VRNA) on Capital Employed’s Substack by Patients Capital Management. In ...

By 2023, the tone had shifted. Venture capital cooled. According to CB Insights, funding for AI drug discovery start-ups ...

TEVA stock jumps 21.6% in three months on branded drug growth, biosimilar launches, and margin-boosting cost cuts.

According to Benzinga Pro, Teva Pharmaceutical Indus's peer group average for short interest as a percentage of float is 3.59 ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the most promising stocks according to Wall Street analysts.

Teva is proud to be included in the 2025 TIME and Statista list of the World’s Most Sustainable Companies, a recognition that underscores our commitment to building a healthier, more sustainable world ...

Teva Pharmaceutical Industries will release its Q2 2025 financial results on July 30, 2025, with a conference call following.

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a different kind of global biopharmaceutical leader, one that operates across the full spectrum of innovation to reliably deliver ...

Teva retains all development, manufacturing and commercialization rights to the licensed molecule in the rest of the world. The strategic partnership presents a significant step forward in the global ...